The Latest Breaking News from IIL

Indian Immunologicals begins construction of Rs.700 cr veterinary vaccine facility in Hyderabad’s Genome Valley

IIL starts construction of Rs.700 crore veterinary vaccine manufacturing facility in Hyderabad's Genome Valley, which is expected to create 750 direct and indirect jobs.

The Hindu · Dec 28, 2023

Indian Immunologicals Ltd commemorates 25 yrs of Human Biologicals Institute, announces new vaccines

Indian Immunologicals Ltd, a subsidiary of the National Dairy Development Board (NDDB) marked a significant milestone as its human health division, Human Biologicals Institute (HBI), celebrated its 25th year since its inception on Saturday. Read further on Dynamite News:

Dynamite News · Nov 25, 2023

Indian Immunologicals launches measles and rubella vaccine for children

IIL launches Mabella, a safe and effective measles and rubella vaccine, to address the urgent need for control of deadly diseases. HBI, established in 1998, developed India's first safe vero-cell rabies vaccine Abhayrab and other vaccines for children. IIL is now one of the largest suppliers of human vaccines to…

The Hindu · Nov 25, 2023